Paper29367756
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA and 10 others. Oncogene, 2018. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. Papers, record 29367756. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29367756
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Muscle Neoplasms | Major topic |
| Oncogene Proteins, Fusion | Major topic |
| Paired Box Transcription Factors | Major topic |
| Rhabdomyosarcoma, Alveolar | Major topic |
| Animals | |
| Cell Proliferation | |
| Cell Transformation, Neoplastic | |
| Cells, Cultured | |
| Child | |
| Female | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Gene Knockdown Techniques | |
| HEK293 Cells | |
| Humans | |
| Mice | |
| Mice, SCID | |
| Microarray Analysis |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 CA151649 | NCI NIH HHS | United States | K08CA151649 | PubMed and NIH | NIH RePORTER |
| P30 CA021765 | NCI NIH HHS | United States | P30CA021765 | PubMed and NIH | NIH RePORTER |
| R01 CA216344 | NCI NIH HHS | United States | R01CA216344 | PubMed and NIH | NIH RePORTER |
| R25 CA023944 | NCI NIH HHS | United States | R25CA023944 | PubMed and NIH | NIH RePORTER |
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19859555 | Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells. | PLoS One | 2009 | https://conductscience.org/library/papers/19859555 | PubMed |
| 2 | 24332040 | Targeting oxidative stress in embryonal rhabdomyosarcoma. | Cancer Cell | 2013 | https://conductscience.org/library/papers/24332040 | PubMed |
| 3 | 25533034 | MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome. | Blood | 2015 | https://conductscience.org/library/papers/25533034 | PubMed |
| 4 | 15342383 | Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas. | Cancer Res | 2004 | https://conductscience.org/library/papers/15342383 | PubMed |
| 5 | 11059777 | Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. | Cancer Res | 2000 | https://conductscience.org/library/papers/11059777 | PubMed |
| 6 | 22082479 | miR221/222 in cancer: their role in tumor progression and response to therapy. | Curr Mol Med | 2012 | https://conductscience.org/library/papers/22082479 | PubMed |
| 7 | 20142475 | Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20142475 | PubMed |
| 8 | 8035804 | Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. | Mol Cell Biol | 1994 | https://conductscience.org/library/papers/8035804 | PubMed |
| 9 | 9024692 | Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. | J Cell Biol | 1997 | https://conductscience.org/library/papers/9024692 | PubMed |
| 10 | 23980150 | Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23980150 | PubMed |
| 11 | 16849646 | MicroRNAs modulate the angiogenic properties of HUVECs. | Blood | 2006 | https://conductscience.org/library/papers/16849646 | PubMed |
| 12 | 25022902 | Identification and consequences of miRNA-target interactions--beyond repression of gene expression. | Nat Rev Genet | 2014 | https://conductscience.org/library/papers/25022902 | PubMed |
| 13 | 22454413 | PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22454413 | PubMed |
| 14 | 27325641 | OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. | Cancer Res | 2016 | https://conductscience.org/library/papers/27325641 | PubMed |
| 15 | 28209991 | MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28209991 | PubMed |
| 16 | 8917562 | Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8917562 | PubMed |
| 17 | 26844700 | MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/26844700 | PubMed |
| 18 | 23206814 | Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. | Skelet Muscle | 2012 | https://conductscience.org/library/papers/23206814 | PubMed |
| 19 | 26258795 | Role of MicroRNAs-221/222 in Digestive Systems. | J Clin Med | 2015 | https://conductscience.org/library/papers/26258795 | PubMed |
| 20 | 24436047 | Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. | Cancer Discov | 2014 | https://conductscience.org/library/papers/24436047 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42151502 | Targeting fusion proteins in solid tumors: from oncogenic mechanisms to clinical interventions. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42151502 | PubMed |
| 41827898 | Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps. | Cells | 2026 | https://conductscience.org/library/papers/41827898 | PubMed |
| 41748289 | Canonical microRNA loss drives tumor development, implicating therapeutic efficacy of enoxacin in angiosarcoma. | RNA | 2026 | https://conductscience.org/library/papers/41748289 | PubMed |
| 40791353 | Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma. | bioRxiv | 2025 | https://conductscience.org/library/papers/40791353 | PubMed |
| 40586712 | The PAX3-FOXO1 fusion gene reduces cell-ECM interactions and TGFβ signaling in rhabdomyosarcoma. | J Cell Biol | 2025 | https://conductscience.org/library/papers/40586712 | PubMed |
| 40508013 | Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508013 | PubMed |
| 39448867 | Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma. | Oncogene | 2025 | https://conductscience.org/library/papers/39448867 | PubMed |
| 39385294 | Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39385294 | PubMed |
| 39200384 | Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200384 | PubMed |
| 39107918 | Extracellular RNA in oncogenesis, metastasis and drug resistance. | RNA Biol | 2024 | https://conductscience.org/library/papers/39107918 | PubMed |
| 38771248 | miR-497 Target Gene Regulatory Network in Angiosarcoma. | Mol Cancer Res | 2024 | https://conductscience.org/library/papers/38771248 | PubMed |
| 38020905 | Differentiation-dependent chromosomal organization changes in normal myogenic cells are absent in rhabdomyosarcoma cells. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/38020905 | PubMed |
| 37968277 | PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors. | Nat Commun | 2023 | https://conductscience.org/library/papers/37968277 | PubMed |
| 37864270 | Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathway. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37864270 | PubMed |
| 37259348 | BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37259348 | PubMed |
| 37052491 | Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions. | Mol Cancer Res | 2023 | https://conductscience.org/library/papers/37052491 | PubMed |
| 36982236 | Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982236 | PubMed |
| 36765536 | MicroRNAs in the Pathogenesis, Prognostication and Prediction of Treatment Resistance in Soft Tissue Sarcomas. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765536 | PubMed |
| 36514216 | circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD. | Acta Biochim Biophys Sin (Shanghai) | 2022 | https://conductscience.org/library/papers/36514216 | PubMed |
| 36395771 | PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. | Mol Cell | 2022 | https://conductscience.org/library/papers/36395771 | PubMed |
Genes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29367756
GET https://conductscience.org/api/papers/v1/29367756/references?page=2